Skip to main content

Grey Matters Health Inc.

corporate_fare Company Profile

Grey Matters Health Inc.

AGNPF·OTC·Life Sciences·CIK 0001642178

Grey Matters Health Inc. is a clinical-stage pharmaceutical development company operating in Canada and Australia. The company is dedicated to developing therapeutic drugs for non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke. Its drug pipeline includes repirinast, which is being developed for the treatment of chronic kidney disease, and N,N-Dimethyltryptamine, which is being developed for the treatment of strokes and traumatic brain injuries. The company was incorporated in 2015 under its former name, Algernon Health Inc., and subsequently changed its name to Grey Matters Health Inc. in April 2026. Grey Matters Health Inc. is headquartered in Vancouver, Canada.

Grey Matters Health Inc. (OTC:AGNPF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for AGNPF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above.

Recent high-impact activity:

  • Grey Matters Closes $600K First Tranche of Private Placement
  • Grey Matters Secures Final Regulatory License for Florida Neuroimaging Clinic
  • Grey Matters Closes $1.25M Private Placement, Insiders Invest $449K
  • Grey Matters Closes CAD $500K First Tranche of Private Placement, Insiders Invest
Browse all tickers starting with A →
$0.3693 -0.05% today
52-week range · as of 2026-09-10 $0.2183 – $8.11
Market cap
$3.3M
Volume
5.7K (1.2× avg)
3-mo avg 4.7K
Live data · 2026-09-12 19:48 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AGNPF - Latest Insights

AGNPF
Sep 10, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Grey Matters Closes $600K First Tranche of Private Placement
Price at Filing: $0.3693
Real-time Price: $0.3693 info
Change: $0 (0%) info
Market Cap: $3.295M info
Sentiment: Positive
View Wiseek Article
AGNPF
Aug 20, 2026, 9:08 AM EDT
Source: GlobeNewswire
Importance Score:
7
Grey Matters Secures Final Regulatory License for Florida Neuroimaging Clinic
Price at Filing: $0.3254
Real-time Price: $0.3693 info
Change: +$0.0439 (+13%) info
Market Cap: $3.295M info
Sentiment: Positive
View Wiseek Article
AGNPF
Jun 18, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Grey Matters Closes $1.25M Private Placement, Insiders Invest $449K
Price at Filing: $0.355
Real-time Price: $0.3693 info
Change: +$0.0143 (+4%) info
Market Cap: $3.295M info
Sentiment: Positive
View Wiseek Article
AGNPF
Jun 05, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Grey Matters Closes CAD $500K First Tranche of Private Placement, Insiders Invest
Price at Filing: $0.3412
Real-time Price: $0.3693 info
Change: +$0.0281 (+8%) info
Market Cap: $3.295M info
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets